PMID- 18837652 OWN - NLM STAT- MEDLINE DCOM- 20081216 LR - 20181113 IS - 1557-7716 (Electronic) IS - 1523-0864 (Print) IS - 1523-0864 (Linking) VI - 11 IP - 1 DP - 2009 Jan TI - H2S protects against methionine-induced oxidative stress in brain endothelial cells. PG - 25-33 LID - 10.1089/ars.2008.2073 [doi] AB - Homocysteine (Hcy) causes cerebrovascular dysfunction by inducing oxidative stress. However, to date, there are no strategies to prevent Hcy-induced oxidative damage. Hcy is an H2S precursor formed from methionine (Met) metabolism. We aimed to investigate whether H2S ameliorated Met-induced oxidative stress in mouse brain endothelial cells (bEnd3). The bEnd3 cells were exposed to Met treatment in the presence or absence of NaHS (donor of H2S). Met-induced cell toxicity increased the levels of free radicals in a concentration-dependent manner. Met increased NADPH-oxidase-4 (NOX-4) expression and mitigated thioredxion-1(Trx-1) expression. Pretreatment of bEnd3 with NaHS (0.05 mM) attenuated the production of free radicals in the presence of Met and protected the cells from oxidative damage. Furthermore, NaHS enhanced inhibitory effects of apocynin, N-acetyl-l-cysteine (NAC), reduced glutathione (GSH), catalase (CAT), superoxide dismutase (SOD), Nomega-nitro-l-arginine methyl ester (L-NAME) on ROS production and redox enzymes levels induced by Met. In conclusion, the administration of H2S protected the cells from oxidative stress induced by hyperhomocysteinemia (HHcy), which suggested that NaHS/H2S may have therapeutic potential against Met-induced oxidative stress. FAU - Tyagi, Neetu AU - Tyagi N AD - Department of Physiology and Biophysics, School of Medicine, University of Louisville, Louisville, Kentucky 40202, USA. suresh.tyagi@louisville.edu FAU - Moshal, Karni S AU - Moshal KS FAU - Sen, Utpal AU - Sen U FAU - Vacek, Thomas P AU - Vacek TP FAU - Kumar, Munish AU - Kumar M FAU - Hughes, William M Jr AU - Hughes WM Jr FAU - Kundu, Soumi AU - Kundu S FAU - Tyagi, Suresh C AU - Tyagi SC LA - eng GR - R01 HL088012-03/HL/NHLBI NIH HHS/United States GR - R01 NS051568/NS/NINDS NIH HHS/United States GR - R01 HL088012/HL/NHLBI NIH HHS/United States GR - NS-51568/NS/NINDS NIH HHS/United States GR - HL-75185/HL/NHLBI NIH HHS/United States GR - R01 NS051568-02/NS/NINDS NIH HHS/United States GR - HL-71010/HL/NHLBI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PL - United States TA - Antioxid Redox Signal JT - Antioxidants & redox signaling JID - 100888899 RN - 0 (Acetophenones) RN - 0 (Formazans) RN - 0 (Reactive Oxygen Species) RN - 0 (Tetrazolium Salts) RN - 0LVT1QZ0BA (Homocysteine) RN - 23305-68-2 (MTT formazan) RN - AE28F7PNPL (Methionine) RN - B6J7B9UDTR (acetovanillone) RN - EC 1.11.1.6 (Catalase) RN - EC 1.15.1.1 (Superoxide Dismutase) RN - GAN16C9B8O (Glutathione) RN - V55S2QJN2X (NG-Nitroarginine Methyl Ester) RN - WYQ7N0BPYC (Acetylcysteine) RN - YY9FVM7NSN (Hydrogen Sulfide) SB - IM MH - Acetophenones/metabolism MH - Acetylcysteine/metabolism MH - Animals MH - Brain/*cytology MH - Catalase/metabolism MH - Cell Line, Transformed MH - Cell Survival/drug effects MH - Dose-Response Relationship, Drug MH - Endothelial Cells/drug effects/*metabolism MH - Formazans/metabolism MH - Glutathione/metabolism MH - Homocysteine/biosynthesis MH - Hydrogen Sulfide/metabolism/pharmacology/*therapeutic use MH - Methionine/*toxicity MH - Mice MH - Models, Biological MH - NG-Nitroarginine Methyl Ester/metabolism MH - Oxidative Stress/*drug effects MH - Reactive Oxygen Species/metabolism MH - Superoxide Dismutase/metabolism MH - Tetrazolium Salts/metabolism MH - Time Factors PMC - PMC2742910 EDAT- 2008/10/08 09:00 MHDA- 2008/12/17 09:00 PMCR- 2010/01/01 CRDT- 2008/10/08 09:00 PHST- 2008/10/08 09:00 [pubmed] PHST- 2008/12/17 09:00 [medline] PHST- 2008/10/08 09:00 [entrez] PHST- 2010/01/01 00:00 [pmc-release] AID - 10.1089/ars.2008.2073 [pii] AID - 10.1089/ars.2008.2073 [doi] PST - ppublish SO - Antioxid Redox Signal. 2009 Jan;11(1):25-33. doi: 10.1089/ars.2008.2073.